Diuretics are one of the most widely prescribed groups of drugs in medical practice and are currently utilized for the treatment of a variety of clinical disorders.


Loop Diuretic Thiazide Diuretic Diuretic Therapy Metabolic Alkalosis Nephrogenic Diabetes Insipidus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rector FC Jr, Carter NW, Seidin DW: The mechanism of bicarbonate reabsorption in the proximal and distal tubules of the kidney. J Clin Invest 44: 278–290, 1965.PubMedCrossRefGoogle Scholar
  2. 2.
    Burg MB: Renal handling of sodium chloride, water, amino acids, and glucose. In Brenner BM, Rec tor FC Jr (eds): The kidney, vol. 1. WB Saunders, Philadelphia, pp 328–370, 1981.Google Scholar
  3. 3.
    Kawamura S, Imai M, Seldin DW, Kokko JP: Char-acteristics of salt and water transport in superficial and juxtamedullary straight segments of proximal tubules. J Clin Invest 55: 1269–1277, 1975.PubMedCrossRefGoogle Scholar
  4. 4.
    Kokko JP: Sodium chloride and water transport in the descending limb of Henle. J Clin Invest 49: 1838–1846, 1970.PubMedCrossRefGoogle Scholar
  5. 5.
    Burg M, Green N: Function of the thick ascending limb of Henle’s loop Am J Physiol 224: 659–668, 1973.Google Scholar
  6. 6.
    Imai M, Kokko JP: Sodium chloride, urea, and wa ter transport in the thin ascending limb of Henle. Generation of osmotic gradient by passive diffusion of solutes. J Clin Invest 53: 393 - 402, 1974.PubMedCrossRefGoogle Scholar
  7. 7.
    Rocha AS, Kokko JP: Sodium chloride and water transport in the medullary thick ascending limb of Henle: evidence for active chloride transport. J Clin Invest 52: 612–623, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Johnston PA, Battelana CA, Lacy F, Jamison R: Evidence for a concentration gradient favoring out-ward movement of sodium in the thin loop of Henle. J Clin Invest 59: 234–240, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Gross JB, Imai M, Kokko JP: A functional compar-ison of the cortical collecting tubule and the distal convoluted tubule. J Clin Invest 55: 1284–1294, 1975.PubMedCrossRefGoogle Scholar
  10. 10.
    Malnic G, Klose RM, Giebisch G: Micropuncture study of distal tubular potassium and sodium transport in the rat nephron. Am J Physiol 211:529– 547, 1966.PubMedGoogle Scholar
  11. 11.
    Good DW, Wright FS: Luminal influences on potas-sium secretion and fluid flow rate. Am J Physiol 236: F192–205, 1979.Google Scholar
  12. 12.
    Khuri RN, Wiederholt M, Sheridan N, Giebisch G: Effects of flow rate and potassium intake on distal tubular potassium transfer. Am J Physiol 228: 1249–1261, 1975.PubMedGoogle Scholar
  13. 13.
    Kunau RT: The influence of carbonic anhydrase inhibitor benzolamide (CI-11366) on reabsorption of chloride, sodium, and bicarbonate in the proximal tubule of the rat. J Clin Invest 51: 294–306, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Chou A, Porush JG, Slater PA, Flombaum CD, Shaft T, Fein PA: Effects of acetazolamide on proxi mal tubule CI, Na, HC03 transport in normal and acidotic dogs during distal blockade. J Clin Invest 60: 162–170, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Burg M, Green N: Effect of mersalyl on the thick ascending limb of Henle’s loop. Kidney Int 4: 245–251, 1973.PubMedCrossRefGoogle Scholar
  16. 16.
    Burg M, Green N: Effect of ethacrynic acid on the thick ascending limb of Henle’s loop. Kidney Int 4: 301–308, 1973.PubMedCrossRefGoogle Scholar
  17. 17.
    Burg M, Stoner L, Cardinal J, Green N: Furosemide effect on isolated tubules. Am J Physiol 225: 119–124, 1973.PubMedGoogle Scholar
  18. 18.
    Imai M: Effect of bumetanide and furosemide on the thick ascending limb of Henle’s loop of rabbits and rats perfused in vitro. Eur J Pharmacol 41:409– 416, 1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Holland SD, Williamson HE: Probenecid inhibition of bumetanide-induced natriuresis in the dog. Proc Soc Exp Biol Med 161: 299–302, 1979.PubMedGoogle Scholar
  20. 20.
    Honari J, Blair AD, Cutler RE: Effects of probene cid on furosemide kinetics and natriuresis in man. Clin Pharmacol Ther 22: 395–401, 1977.PubMedGoogle Scholar
  21. 21.
    Lant AF: Effects of bumetanide on cation and anion transport. Postgr Med J 51 (Suppl 6): 35–2, 1975.Google Scholar
  22. 22.
    Velasquez MT, Wan SH, Barr JW, Maronde RF: Effect of probenecid on the natriuresis and renin release induced by bumetanide in man. J Clin Phar-macol 21: 657–662, 1981.Google Scholar
  23. 23.
    Ebell H: Effects of diuretics on renal Na-K ATPase and arenyl cyclase. Naunyn Schmiedebergs Arch Pharmakol 281: 301–314, 1974.CrossRefGoogle Scholar
  24. 24.
    Kramer HJ: Effects of bumetanide on sodium trans-port of the isolated frog skin and on renal Na-K- ATPase. Pharmacol 14: 481–489, 1976.CrossRefGoogle Scholar
  25. 25.
    Burg M, Stoner L: Renal tubular chloride transport and mode of action of some diuretics. Ann Rev Physiol 38: 37–45, 1976.CrossRefGoogle Scholar
  26. 26.
    Wright JT, Corder CN, Taylor R: Studies on rat kidney 15-hydroxy-prostaglandin dehydrogenase. Biochem Pharmacol 25: 1669–1673, 1976.PubMedCrossRefGoogle Scholar
  27. 27.
    Stokes J: Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibition of the medullary portion. J Clin Invest 64: 495–502, 1979.PubMedCrossRefGoogle Scholar
  28. 28.
    Bailie MD, Barbour JA, Hook JB: Effects of indo- methacin on furosemide-induced changes in renal blood flow. Proc Soc Exp Biol Med 148: 1173–1176, 1975.PubMedGoogle Scholar
  29. 29.
    Olsen UB: Indomethacin inhibition of bumetanide diuresis in dogs. Acta Pharmacol Toxicol 37: 65–78, 1975.CrossRefGoogle Scholar
  30. 30.
    Patak RV, Mookerjee BK, Bentzel CJ, Hysert PE, Babej M, Lee JB: Antagonism of the effects of furo-semide by indomethacin in normal and hypertensive man. Prostaglandins 10: 649–659, 1975.PubMedCrossRefGoogle Scholar
  31. 31.
    Kunau RT, Weller DR, Webb HL: Clarification of the site of action of chlorothiazide in the rat nephron. J Clin Invest 56: 401–407, 1975.PubMedCrossRefGoogle Scholar
  32. 32.
    Edelman IS, Fimognari GM: On the biochemical mechanisms of action of aldosterone. Recent Prog Horm Res 24: 1–44, 1968.PubMedGoogle Scholar
  33. 33.
    Crabbe J: A hypothesis concerning the mode of action of amiloride and triamterene. Arch Int Phar- macodyn Ther 173: 474–477, 1978.Google Scholar
  34. 34.
    Manuel MA, Berne GJ, Wagnaild JT, Weiner MW: An effect of spironolactone on urinary acidification in normal man. Arch Intern Med 134: 472–474, 1974.PubMedCrossRefGoogle Scholar
  35. 35.
    Flamenbaum W, Friedman R: Pharmacology, ther-apeutic efficacy and adverse effects of bumetanide, a new “loop” diuretic. Pharmacotherapy 2: 213–222, 1982.PubMedGoogle Scholar
  36. 36.
    Gabriel R, Baylor P: Comparison of the chronic effects of bendrofluazide, bumetanide and furose- mide on plasma biochemical variables, Postgr Med J 57: 71–74, 1981.CrossRefGoogle Scholar
  37. 37.
    Maronde RF, Quinn M: Double blind comparisons of furosemide and bumetanide. Clin Pharmacol Ther 21: 110–113, 1972.Google Scholar
  38. 38.
    Velasquez MT, Wan SH, Maronde RF: Bumeta- nide-induced rise in plasma renin activity. Clin Phar macol Ther 24: 186–191, 1978.Google Scholar
  39. 39.
    Campbell DB, Moore RA: The pharmacology and clinical pharmacology of indapamide. Postgr Med J 57 (Suppl 2): 7–17, 1981.Google Scholar
  40. 40.
    Uhlich E, Troger C, Knoll W: Effects of indapamide in hypertensive patients and on experimental vascu lar reactivity. Cur Med Res Opin 5 (Suppl 1): 71, 1977.CrossRefGoogle Scholar
  41. 41.
    Mironneau J, Gargouil YM: Action of indapamide on excitation-contraction coupling in vascular smooth muscle. Eur J Pharmacol 57: 57–67, 1979.PubMedCrossRefGoogle Scholar
  42. 42.
    Acchiardo SR, Skoutakis VA: Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment. Am Heart J 106: 237–244, 1983.PubMedCrossRefGoogle Scholar
  43. 43.
    Perez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodes J: Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with as cites. Gastroenterology 84: 961–968, 1983.PubMedGoogle Scholar
  44. 44.
    Freis ED: How diuretics lower blood pressure. Am Heart J 106: 185–187, 1983.PubMedCrossRefGoogle Scholar
  45. 45.
    Crawford JD, Kennedy GC, Hill LE: Clinical re sults of treatment of diabetes insipidus with drugs of the chlorothiazide series. N Engl J Med 262: 737–743, 1960.PubMedCrossRefGoogle Scholar
  46. 46.
    Kassirer JP, Harrington JT: Diuretics and potas sium metabolism: a reassessment of the need, effec tiveness, and safety of potassium therapy. Kidney Int 11: 505–515, 1977.PubMedCrossRefGoogle Scholar
  47. 47.
    Maronde RF, Milgrom M, Dickey JM: Potassium loss with thiazide therapy. Am Heart J 78: 16–21, 1969.PubMedCrossRefGoogle Scholar
  48. 48.
    Tweeddale MG, Ogilvie RI, Ruedy J: Antihyperten-sive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 22: 519–527, 1977.PubMedGoogle Scholar
  49. 49.
    Helderman JH, Elahi D, Andersen DK, Rizes GS, Tobin JD, Shocken D, Andres R: Prevention of the glucose intolerance of thiazide diuretics by main-tenance of body potassium. Diabetes 32: 106–11, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • Manuel T. Velasquez

There are no affiliations available

Personalised recommendations